[1] Ghoneim MA,Abdel-Latif M,Mekresh M,et al. Radical cystectomy for carcinoma of the bladder:2,720 consecutive cases 5 years later[J]. J Urol ,2008,180 (1):121-127. [2] Shariat SF,Karakiewicz PI,Palapattu GS,et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder:A contemporary series from the bladder cancer research consortium[J]. J Urol,2006,176 (6 Sup 1):2414-2422. [3] Garg M,Kanojia D,Khosla A,et al. Sperm-associated antigen 9 is associated with tumor growth,migration,and invasion in renal cell carcinoma[J]. Cancer Res,2008,68 (20):8240-8248. [4] Garg M,Kanojia D,Salhan S,et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma[J]. Cancer, 2009, 115 (12):2671-2683. [5] Peng Yu,Lei Yan,Hui Zhang,et al. Expression and clinical significance of sperm-associated antigen 9 in patients with endometrial carcinoma[J]. Internat J Gynecol Cancer,2012,22 (1):87-93. [6] Jagadish N,Rana R,Selvi R,et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein[J]. Biochem J,2005,389 (Sup 1):73–82. [7] Shankar S,Mohapatra B,Suri A. Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells,having unique palindromic sequences and encoding a leucine zipper dimerization motif[J]. Biochem Biophys Res Commun,1998,243 (2):561–565. [8] Qi M,Elion EA. MAP kinase pathways[J]. J Cell Sci,2005, 118 (16):3569–3572. [9] Kim M,Murakami A,Kawabata K,et al. Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells[J]. Carcinogenesis,2005,26 (9):1553–1562. [10] Collins CS,Hong J,Sapinoso L,et al. A small interfering RNA screen for modulators of tumor cell motility identifiesMAP4K4 as a pro-migratory kinase[J]. Proc Natl Acad Sci USA, 2006, 103 (10):3775–3780. [11] Hernandez S,Lopez-Knowles E,Lioreta J,et al. Prospective study of FGFR3 mutations as a prognostic factor in non-muscle-invasive urothelial bladder carcinomas[J]. Eur Urol ,2008,54 (4):835–843. [12] Zendman AJ,Ruiter DJ,Van-Muijen GN. Cancer/testis-associated genes:identification,expression profile,and putative function[J]. J Cell Physiol,2003,194 (3):272-288. [13] Garg M,Chaurasiya D,Rana R,et al. Sperm-associated antigen 9,a novel cancer testis antigen,is a potential target for immunotherapy in epithelial ovarian cancer[J]. Clin Cancer Res,2007,13 (5):1421-1428. [14] Wei CL,Wu Q,Vega SV,et al. A global map of p53 transcription-factor binding sites in the human genome[J]. Cell, 2006,124 (1):207-219. [15] Bernardini S,Billerey C,Martin M,et a1. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma[J].J Urol, 2001,165 (1):42-46,526-528. [16] Kanojia D,Garg M,Gupta S,et a1. Sperm associated antigen 9,a novel biomarker for early detection of breast cancer[J]. Cancer Epidemiol Biomarkers Prev,2009,18 (2):630-639. [17] Scudellari M. A ballsy search for cancer targets[J]. Nat Med, 2011,17 (8):916-918. |